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istics seem to be related to a worse prognosis than
the usual well-differentiated myeloma and give rise to
a differential diagnosis of myeloid or monocytic
leukemia, lymphoma or nonhematologic malignan-
cy.2,5,6 Although the expression of CD13 and CD33
antigens on normal plasma cells has been reported,
the presence of the myeloid antigen CD13 on myelo-
ma cells is an uncommon finding. Since CD13 anti-
gen is expressed by cells of the granulocytic and
monocytic lineages, its presence on plasma cells sup-
ports the hypothesis of an early stem cell disorder in
the development of PCL.7 Morphological features of
the atypical cells in this patient initially suggested
undifferentiated blast cells rather than plasmablast
A58-year-old woman was hospitalized becauseof weakness, edema of the extremities andascites. Physical examination revealed pallor
and liver enlargement. Biological findings were as
follows: hemoglobin 9.3 g/dL, leukocyte count
72.83109/L, with 85% atypical cells, platelet count
1313109/L, increased lactic dehydrogenase (780
U/L) and b2-microglobulin (16.9 mg/L). Serum pro-
tein electrophoresis revealed severe hypogamma-
globulinemia, and monoclonal kappa light chain
(800 mg/dL) was found in the urine. No liver or kid-
ney dysfunction was detected by serum biochemical
determinations and no abnormalities were seen on
the X-ray study.
Bone marrow aspirate smears revealed almost
complete replacement of the bone marrow by a dif-
fuse infiltration of cells showing similar features to
those observed in the peripheral blood smears. Many
of these cells were large, with abundant, moderate-
ly basophilic cytoplasm, and contained two to three
distinct nuclear lobes. Other cells had cleaved nuclei,
giving them a monocytoid appearance. The nuclei
with lobulation were often of different size and occa-
sionally had prominent nucleoli (Figure 1). Neo-
plastic cells were peroxidase, PAS and Sudan nega-
tive, and acid phosphatase positive, with the reac-
tivity distributed in granules in the cytoplasm. A mas-
sive infiltration of cells with cleaved nuclei was also
noted in the sinusoids of a liver biopsy that was per-
formed to exclude hepatic disease as being the ori-
gin of the ascites (Figure 2). Flow cytometry of bone
marrow cells showed an intense reactivity with CD38
and CD13 antibodies and the presence of cytoplas-
matic k light chains. The stem cell antigen CD34,
and the myelomonocytic antigens CD33, CD14 and
CD15 were negative.
Plasma cell leukemia has been defined as a clonal
proliferation in which the number of plasma cells in
the blood is greater than 20 percent of the total
leukocytes or the absolute plasma cell count exceeds
23109/L.1 The neoplastic cells in most cases closely
resemble normal plasma cells, although sometimes
plasma cell leukemia with aberrant morphologic fea-
tures (cleaved, monocytoid or multilobated nuclei)
has been reported.2-4 These morphologic character-
Figure 2. Liver biopsy with sinusoidal infiltrate of monocy-
toid cells (Hematoxylin-eosin, original magnification 3400).
Figure 1. Bone marrow aspirate smear showing blasts cells
with cleaved and multilobated nuclei (May-Grünwald-Giem-
sa, original magnification 31200).
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or typical plasma cells, however the immunopheno-
type findings allowed us to make the final diagnosis
of plasma cell leukemia.
The cytogenetic study performed on bone marrow
cells showed an abnormal cellular clone with complex
karyotype in all 26 mitoses examined: 46,XX, del(1)
(q21), +der(1), -5,-8,t(12;?) (q22;?), -14, add(14)
(q32), +3mar. Although these abnormalities are not
specific to PCL, abnormalities of chromosome 14, pri-
marily 14q+, are present in 50% of the patients suffer-
ing the PCL with abnormal karyotype.8 Besides, dupli-
cations and deletions of chromosomes 1 and 8 are also
commonly involved in PCL. Therefore, karyotype find-
ings were very useful in order to confirm this patient’s
diagnosis.
The patient was treated monthly with VAD (vin-
cristine, doxorubicin and dexamethasone) cycles.
After receiving two cycles both clinical and biochem-
ical data improved but the patient suddenly died
from cerebral hemorrhage. We conclude that recog-
nition of aberrant features of plasma cells is helpful
in the differential diagnosis of plasma cell leukemia
and myeloma from other hematopoietic neoplasms
and occasionally from metastatic tumors.
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